Virtual Medicinal Product (VMP) - Morphine tartrate 15mg/1ml / Cyclizine tartrate 50mg/1ml solution for injection ampoules

Navigation

Name Details

Name Start Date End Date
Name Current Name Morphine tartrate 15mg/1ml / Cyclizine tartrate 50mg/1ml solution for injection ampoules Start Date 30-04-2010 End Date
Previous Name Previous Name Cyclizine tartrate 50mg/1ml / Morphine tartrate 15mg/1ml solution for injection ampoules Start Date 18-05-2004 End Date 29-04-2010
Abbreviated Name Abbreviated Name Morphine tartrate 15mg/1ml / Cyclizine tartrate 50mg inj amp Start Date 30-04-2010
Previous Abbreviated Name Cyclizine tartrate 50mg / Morphine tartrate 15mg/1ml inj amp Previous Start Date 01-05-2009 Previous End Date 29-04-2010

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
ml
Unit Dose UOM
ampoule

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
Schedule 2 (CD)
Route
Subcutaneous, Intramuscular, Intravenous
Form
Solution for injection
Ontology Form/Route
solutioninjection.subcutaneous, solutioninjection.intramuscular, solutioninjection.intravenous
Non-availability Indicator
Actual Products not Available
Name Basis
Other

Codes

ATC Code
N02AA51
BNF Start Date End Date
Current BNF 04070200 Start Date 04-04-2022 End Date
Previous BNF 04070200 Start Date 18-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
3897411000001102 17-02-2003

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Cyclizine tartrate Based on Ingredient Substance 50 mg 1 ml
Morphine tartrate Based on Ingredient Substance 15 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
5 ampoule
10 ampoule